Table 2.
eGFR (mL/min/1.73 m2) | |||||||
---|---|---|---|---|---|---|---|
90+ n = 2,447 42 AAAs (2%) |
75–89 n = 4,172 117 AAAs (3%) |
60–74 n = 2,903 121 AAAs (4%) |
45–59 n = 838 43 AAAs (5%) |
30–44 n = 291 20 AAAs (7%) |
<30 n=73 4 AAAs (5%) |
p for trend |
|
Model 1 | Reference | 1.18 (0.82–1.70) | 1.62 (1.11–2.35) | 2.03 (1.29–3.19) | 3.29 (1.89–5.72) | 4.44 (1.58–12.49) |
<0.001 |
Model 2 | Reference | 1.06 (0.74–1.53) | 1.39 (0.95–2.03) | 1.41 (0.89–2.25) | 1.93 (1.09–3.44) | 1.97 (0.68–5.65) | 0.035 |
Model 1 adjusted for age, gender, race, and center, and Model 2 further adjusted for smoking status, alcohol intake, BMI, systolic and diastolic blood pressures, anti-hypertensive medication, diabetes, total and HDL cholesterols, prevalent stroke, CHD, HF, and ACR. p for trend was based on eGFR as a continuous variable below 90 ml/min/1.73 m2.